44 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
First Episode of Opportunistic ... #Prophylaxis #Opportunistic ... #Infections #OIs ... HIVAIDS #IDSA #management ... #pharmacology
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
C virus (HCV) infection ... infectiousdisease #hepatology ... HepC #HepatitisC #Management ... #Pharmacology
Flutycosine - Antibiotics Class Overview
 - 
Mechanism: 5-FC interferes with DNA and protein synthesis.  Only
B for initial management ... severe fungal infections ... ) - Main adverse ... effects = Hematologic ... #Pharmacology #Antibiotics
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Papillomavirus Infections ... of mode of HIV infection ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Penicillium marneffei Infections ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Indications and Pharmacology ... Hypotension with rapid injection ... diarrhea & abdominal pain ... #Indications #Pharmacology ... #hematology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Bacterial Enteric Infections ... Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Isospora belli Infection ... General Management ... Prevention #Treatment #management ... #opportunistic ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Prevention #Treatment #management ... #opportunistic ... #infections #HIVAIDS ... #pharmacology